|
Montbugnoil et al.
|
Anti-HCV Ab rapid test (1st IRP 75/537 by Thema Ricerca, WHO Geneva)
|
100
|
50
|
1
|
49
|
0
|
100%
|
98%
|
|
O’Connell, R. J. et al.
|
Axiom (Axiom Diagnostics, Burstadt,Germany)
|
674
|
326
|
10
|
329
|
9
|
97%
|
97%
|
|
O’Connell, R. J. et al.
|
Axiom (Axiom Diagnostics, Burstadt,Germany)
|
168
|
77
|
2
|
82
|
7
|
92%
|
98%
|
|
O’Connell, R. J. et al.
|
Axiom (Axiom Diagnostics, Burstadt,Germany)
|
168
|
82
|
5
|
79
|
2
|
98%
|
94%
|
|
Scalioni Lde, P et al.
|
Bioeasy HCV Rapid Test, (Bioeasy Diagnóstica Ltd., Brazil)
|
194
|
137
|
0
|
48
|
9
|
94%
|
100%
|
|
Scalioni Lde, P et al.
|
Bioeasy HCV Rapid Test (Bioeasy Diagnóstica Ltd., Brazil)
|
194
|
111
|
0
|
48
|
35
|
76%
|
100%
|
|
Scalioni Lde, P et al.
|
Bioeasy HCV Rapid Test (Bioeasy Diagnóstica Ltd., Brazil)
|
194
|
136
|
0
|
48
|
10
|
93%
|
100%
|
|
Jewett, A et al.
|
Chembio DPP HCV Test (Chembio Diagnostic Systems, USA)
|
407
|
101
|
3
|
290
|
8
|
93%
|
99%
|
|
Jewett, A et al.
|
Chembio DPP HCV test (Chembio Diagnostic Systems,USA)
|
400
|
88
|
3
|
294
|
15
|
85%
|
99%
|
|
Smith, B. D et al.
|
Chembio DPP HCV test (Chembio Diagnostic Systems, USA)
|
476
|
308
|
12
|
125
|
32
|
91%
|
91%
|
|
Smith, B. D et al.
|
Chembio DPP HCV test (Chembio Diagnostic Systems, USA)
|
385
|
264
|
3
|
101
|
17
|
94%
|
97%
|
|
Smith et al. et al.
|
Chembio DPP HCV test (Chembio Diagnostic Systems, USA)
|
1081
|
525
|
1
|
543
|
12
|
98%
|
100%
|
|
O’Connell, R. J. et al.
|
CORE (CORE Diagnostics, United Kingdom)
|
168
|
29
|
1
|
83
|
55
|
35%
|
99%
|
|
O’Connell, R. J et al.
|
CORE (CORE Diagnostics, United Kingdom)
|
168
|
24
|
2
|
82
|
60
|
29%
|
98%
|
|
O’Connell, R. J et al.
|
CORE (CORE Diagnostics, United Kingdom)
|
674
|
323
|
7
|
332
|
12
|
96%
|
98%
|
|
Maity et al.
|
Diagnostics Ltd. (other information is not available)
|
300
|
132
|
0
|
168
|
0
|
100%
|
100%
|
|
O’Connell, R. J. et al.
|
FirstVue (AT First Diagnostic, Woodbury,NY, USA)
|
168
|
66
|
0
|
84
|
18
|
79%
|
100%
|
|
O’Connell, R. J. et al.
|
FirstVue (AT First Diagnostic, Woodbury,NY, USA)
|
168
|
54
|
1
|
83
|
30
|
64%
|
99%
|
|
O’Connell, R. J. et al.
|
FirstVue (AT First Diagnostic, Woodbury,NY, USA)
|
674
|
312
|
3
|
336
|
23
|
93%
|
99%
|
|
Al-Tahish et al.
|
Fourth- generation HCV TRI_DOT (J. Mitra Co, India)
|
100
|
34
|
15
|
50
|
1
|
97%
|
77%
|
|
Daniel et al.
|
Fourth- generation HCV TRI_DOT (J. Mitra Co, India)
|
2590
|
138
|
24
|
2427
|
1
|
99%
|
99%
|
|
Kim, M. H. et al.
|
GENEDIA® HCV Rapid LF (Green Cross medical science corp., Korea)
|
100
|
52
|
0
|
34
|
14
|
79%
|
100%
|
|
Kaur et al.
|
HCV Bidot (J. Mitra Co., India)
|
2754
|
28
|
0
|
2722
|
4
|
88%
|
100%
|
|
Al-Tahish
|
HCV one step test device (ACON Laboratories, USA)
|
100
|
34
|
15
|
50
|
1
|
97%
|
77%
|
|
Ivantes et al.
|
HCV Rapid Test Bioeasy (Bioeasy Diagnostica Ltd., Brazil)
|
71
|
30
|
3
|
38
|
0
|
100%
|
93%
|
|
da Rosa et al.
|
HCV Rapid Test Bioeasy® (Standard Diagnostics, South Korea)
|
307
|
100
|
0
|
204
|
3
|
97%
|
100%
|
|
Poovoran et al.
|
HCV-SPOT assay (Genelabs Diagnostics Pty Ltd., Singapore)
|
192
|
41
|
11
|
139
|
1
|
98%
|
93%
|
|
Mvere et al.
|
HCV-SPOT assay (Genelabs Diagnostics Pty Ltd., Singapore)
|
206
|
10
|
4
|
191
|
1
|
91%
|
98%
|
|
Njouom et al.
|
Hexagon® HCV (Not reported manufacturer located country)
|
329
|
160
|
17
|
151
|
1
|
99%
|
90%
|
|
Al-Tahish et al.
|
ImmunoComb II HCV (Inverness Medical Innovations, USA)
|
100
|
34
|
14
|
51
|
1
|
97%
|
78%
|
|
Yarri et al.
|
ImmunoComb II HCV (Inverness Medical Innovations, USA)
|
37
|
18
|
4
|
15
|
0
|
100%
|
79%
|
|
Yarri et al.
|
ImmunoComb II HCV (Inverness Medical Innovations, USA)
|
37
|
18
|
1
|
18
|
0
|
100%
|
95%
|
|
Njouom et al.
|
ImmunoComb® II HCV assay (Orgenics Ltd., not reported manufacturer located country)
|
329
|
103
|
0
|
168
|
58
|
64%
|
100%
|
|
da Rosa et al.
|
Imuno-Rapido HCV® (Wama Diagnostica, Brazil).
|
307
|
100
|
0
|
204
|
3
|
97%
|
100%
|
|
O’Connell, R. J. et al.
|
Instant View Cassette (Alfa Scientific Designs, Poway, CA, USA)
|
674
|
321
|
3
|
336
|
14
|
96%
|
99%
|
|
O’Connell, R. J. et al.
|
Instant View Cassette (Alfa Scientific Designs, Poway, CA, USA)
|
168
|
68
|
3
|
81
|
16
|
81%
|
96%
|
|
O’Connell, R. J. et al.
|
Instant View Cassette (Alfa Scientific Designs, Poway, CA, USA)
|
168
|
46
|
1
|
83
|
38
|
55%
|
99%
|
|
Maity et al.
|
J Mitra Co. India other information is not available)
|
300
|
120
|
0
|
174
|
6
|
95%
|
100%
|
|
Jewett, A et al.
|
Rapid HIV/HCV antibody test (Medmira Laboratories, Canada)
|
374
|
80
|
0
|
274
|
20
|
80%
|
100%
|
|
Nyirenda et al.
|
Monoelisa HCV Ag/Ab ultra-microplate EIA (Bio-Rad, France)
|
202
|
2
|
7
|
186
|
7
|
22%
|
96%
|
|
Tagny et al.
|
Monolisa HCV Ag-Ab Ultra, (BioRad, France)
|
1998
|
26
|
28
|
1929
|
15
|
63%
|
99%
|
|
Smith et al.
|
Multiplo Rapid HIV/HCV Antibody Test (MedMira, Canada)
|
1081
|
474
|
1
|
543
|
63
|
88%
|
100%
|
|
Smith, B. D et al.
|
Multiplo Rapid HIV/HCV Antibody Test (MedMira, Canada)
|
432
|
303
|
8
|
40
|
81
|
79%
|
83%
|
|
Cha, Y. J. et al.
|
OraQuick (OraSure Technologies, PA USA)
|
437
|
134
|
0
|
300
|
3
|
98%
|
100%
|
|
Cha, Y. J. et al.
|
Architect (Abbott Laboratories, Abbott Park, IL, USA)
|
400
|
200
|
0
|
200
|
0
|
100%
|
100%
|
|
Lee, S. R et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2183
|
756
|
1
|
1422
|
1
|
100%
|
100%
|
|
Lee, S. R et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2183
|
755
|
2
|
1420
|
1
|
100%
|
100%
|
|
Lee, S. R et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2183
|
753
|
2
|
1421
|
2
|
100%
|
100%
|
|
Lee, S. R et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2183
|
752
|
1
|
1421
|
2
|
100%
|
100%
|
|
Lee, S. R et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2183
|
739
|
5
|
1418
|
14
|
98%
|
100%
|
|
O’Connell, R. J et al.
|
OraQuick (OraSure Technologies, PA USA)
|
674
|
333
|
1
|
338
|
2
|
99%
|
100%
|
|
O’Connell, R. J et al.
|
OraQuick (OraSure Technologies, PA USA)
|
168
|
83
|
1
|
83
|
1
|
99%
|
99%
|
|
O’Connell, R. J et al.
|
OraQuick (OraSure Technologies, PA USA)
|
168
|
82
|
0
|
84
|
2
|
98%
|
100%
|
|
Smith, B. D et al.
|
OraQuick (OraSure Technologies, PA USA)
|
549
|
375
|
8
|
140
|
26
|
94%
|
.95%
|
|
Smith, B. D et al.
|
OraQuick (OraSure Technologies, PA USA)
|
266
|
188
|
1
|
72
|
5
|
97%
|
99%
|
|
Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
572
|
122
|
0
|
449
|
1
|
99%
|
100%
|
|
Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
572
|
123
|
0
|
449
|
0
|
100%
|
100%
|
|
Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
572
|
123
|
0
|
449
|
0
|
100%
|
100%
|
|
Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
572
|
123
|
1
|
448
|
0
|
100%
|
100%
|
|
Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
572
|
123
|
1
|
448
|
0
|
100%
|
100%
|
|
Smith et al.
|
OraQuick (OraSure Technologies, PA USA)
|
1081
|
533
|
3
|
541
|
4
|
99%
|
99%
|
|
Drobnik et al.
|
OraQuick (OraSure Technologies, PA USA)
|
484
|
92
|
3
|
382
|
7
|
93%
|
99%
|
|
Stephen R. Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2180
|
756
|
1
|
1422
|
1
|
100%
|
100%
|
|
Stephen R. Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2178
|
755
|
2
|
1420
|
1
|
100%
|
100%
|
|
Stephen R. Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2178
|
753
|
2
|
1421
|
2
|
100%
|
100%
|
|
Stephen R. Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2176
|
752
|
1
|
1421
|
2
|
100%
|
100%
|
|
Stephen R. Lee et al.
|
OraQuick (OraSure Technologies, PA USA)
|
2176
|
739
|
5
|
1418
|
14
|
98%
|
100%
|
|
Gao et al.
|
OraQuick (OraSure Technologies, PA USA)
|
1156
|
16
|
6
|
1133
|
1
|
94%
|
99%
|
|
Ibrahim
|
OraQuick (OraSure Technologies, PA USA)
|
160
|
53
|
0
|
100
|
7
|
88%
|
100%
|
|
Scalioni Lde, P_2014
|
OraQuick (OraSure Technologies, PA USA)
|
172
|
108
|
0
|
50
|
14
|
89%
|
100%
|
|
Hess et al.
|
DPP HIV-HCV-Syphilis Assay (Chembio Diagnostic Systems, Inc., Medford, NY).
|
948
|
152
|
6
|
776
|
14
|
92%
|
99%
|
|
Buti et al.
|
Not available
|
188
|
135
|
0
|
50
|
3
|
98%
|
100%
|
|
Yuen et al.
|
SM-HCV Rapid Test (SERO-Med Laborspezialita¨ten GmbH, Eichsta ¨tt, Germany)
|
290
|
98
|
0
|
189
|
3
|
97%
|
100%
|
|
Maity et al.
|
SPAN Diagnostics, Indi, other information is not available
|
300
|
132
|
0
|
168
|
0
|
100%
|
100%
|
|
Kant et al.
|
Toyo anti-HCV test (Turklab, Izmir, Turkey)
|
185
|
82
|
12
|
90
|
1
|
99%
|
88%
|
|
Kosack, C. S. et al.
|
The ImmunoFlow HCV test (Core Diagnostics,United Kingdom)
|
82
|
55
|
0
|
26
|
0
|
100%
|
100%
|
|
Scalioni Lde et al.
|
WAMA Imuno-Rápido HCV Kit (WAMA Diagnóstica, Brazil)
|
194
|
119
|
3
|
45
|
27
|
82%
|
94%
|
|
Scalioni Lde, P et al.
|
WAMA Imuno-Rápido HCV Kit (WAMA Diagnóstica, Brazil)
|
194
|
134
|
3
|
45
|
12
|
92%
|
94%
|
|
Hui et al.
|
Not reported
|
197
|
91
|
0
|
88
|
18
|
83%
|
100%
|
